Second International Conference on Cervical Cancer
نویسندگان
چکیده
Received October 31, 2002; revision received April 25, 2003; accepted April 29, 2003. Recent advances in fiber optics, sources and detectors, imaging, and computercontrolled instrumentation have stimulated a period of unprecedented growth in the development of photonics technologies for a wide variety of diagnostic and therapeutic clinical applications. These include the application of quantitative optical spectroscopy and imaging for the detection of precancerous lesions in the uterine cervix, a topic of interest at the Second International Conference on Cervical Cancer, which was held April 11–14, 2002. Investigators have applied the Littenberg method of emerging technology assessment to new optical methods used to detect cervical neoplasia. Currently, such technologies as fluorescence spectroscopy (the combination of fluorescence and diffuse reflectance spectroscopy), tri-modal spectroscopy, and light-scattering spectroscopy that probe the spectral characteristics of tissue are being investigated. Optical technologies that create images of subcellular structure without biopsy subsequent to pathology that currently are under investigation include in vivo confocal imaging and optical coherence tomography. Numerous small studies have demonstrated the potential of these optical technologies. What remains to be elucidated are the fundamental biophysical origins of variations in remitted optical signals between normal and dysplastic tissue. Large multicenter randomized controlled trials are needed to confirm the detection and imaging capabilities of optical technology. Furthermore, the development of contrast agents that could boost detection with these technologies is needed, and basic biologic characterization of signals should be pursued. Applying the Littenberg assessment will help ensure that superior, not simply alternative, technologies are implemented. Cancer 2003;98(9 Suppl):2015–27. © 2003 American Cancer Society.
منابع مشابه
The second International Conference on Holy Prophet Mohammad’s Tradition (Sireye Nabavi) in Medicine
The second International Conference on Holy Prophet Mohammad’s Tradition (Sireye Nabavi) in Medicine
متن کاملPnm-7: Sexual Function in Women with Cervical Cancer and A History of Pelvic Radiation Therapy
Background Cervical cancer is the second most common cancer in women and is regarded as one of the leading causes of cancer death in developing countries. In cervical cancer patients, both surgery and radiation therapy may bring about sexual dysfunction. Therefore, this study aimed to survey sexual dysfunction in women with cervical cancer and a history study of pelvic radiation therapy in Ghae...
متن کاملP-173: Conservative Treatment in Young Patients with Cervical Cancer: A Review
Background: Fertility preservation in young patients with cervical cancer is a novel point which considers these days and in Iran we have a new experiment that was successful. Materials and Methods: Evaluation of literature review and our experiences in conservative management in patients with early stage cervical cancer. The key words in this research were conservative management, young women ...
متن کاملMessage of President of ISBT to 2nd International Conference on Transfusion Medicine/Plasma Industry in Tehran, Iran, May 10-11, 2011
متن کامل
پیشگیری ،HPV ،سرطان سرویکس، واکسیناسیون
Cervical cancer is the second most common gynecologic cancer. A steady 70% annual decline in mortality from cervical cancers has been observed since the mid 20th century after the introduction of widespread papanicolaou cytological screening. But also cervical cancer continues to be an important world health problem for women. Cervical cancer is one of the best- understood neoplasm given its we...
متن کاملCervical cancer chemoprevention, vaccines, and surrogate endpoint biomarkers.
At the Second International Conference on Cervical Cancer, held April 11-14, 2002, experts in cervical cancer prevention, detection, and treatment reviewed the need for more research in chemoprevention, including prophylactic and therapeutic vaccines, immunomodulators, peptides, and surrogate endpoint biomarkers. Investigators and clinicians noted the need for more rigorous Phase I randomized c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2003